Literature DB >> 12507727

Thr123 of rat G-substrate contributes to its action as a protein phosphatase inhibitor.

Shogo Endo1, Angus C Nairn, Paul Greengard, Masao Ito.   

Abstract

Rat G-substrate cDNA was isolated from a cerebellar library and characterized. The deduced amino acid sequence of rat G-substrate contained two putative phosphorylation sites for PKG at Thr72 and Thr123; the amino acid sequences (KPRRKDT(p)PA) around these sites are conserved in human, mouse and rabbit. G-substrate phosphorylated by PKG inhibited the catalytic subunits of both protein phosphatase-1 (IC(50) 14.1 nM) and -2A (IC(50) 5.9 nM). Mutation of Thr123 (site 2) to Ala significantly reduced the inhibition of both PP-1 and PP-2A, while mutation of Thr72 (site 1) to Ala had little effect on inhibitory activity. In situ hybridization analysis revealed that G-substrate mRNA was localized exclusively in cerebellar Purkinje cells. Immunoperoxidase staining showed that in Purkinje cells, G-substrate was present in somata, dendrites and axons. In rat cerebellar slices, activation of PKG with a nitric oxide (NO) donor, NOR3, or 8-Br-cGMP, increased phosphorylation of G-substrate, as demonstrated with a phosphorylation-specific antibody. These results characterize further the inhibition of PP-1 and PP-2A by phospho-G-substrate, and demonstrate its physiological phosphorylation in rat Purkinje cells. Copyright 2002 Elsevier Science Ireland Ltd and the Japan Neuroscience Society

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12507727     DOI: 10.1016/s0168-0102(02)00199-2

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  6 in total

1.  Protein phosphatase 2A inhibition induces cerebellar long-term depression and declustering of synaptic AMPA receptor.

Authors:  T Launey; S Endo; R Sakai; J Harano; M Ito
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-29       Impact factor: 11.205

Review 2.  cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action.

Authors:  Sharron H Francis; Jennifer L Busch; Jackie D Corbin; David Sibley
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

3.  An endogenous serine/threonine protein phosphatase inhibitor, G-substrate, reduces vulnerability in models of Parkinson's disease.

Authors:  Chee Yeun Chung; James B Koprich; Shogo Endo; Ole Isacson
Journal:  J Neurosci       Date:  2007-08-01       Impact factor: 6.167

4.  Dual involvement of G-substrate in motor learning revealed by gene deletion.

Authors:  Shogo Endo; Fumihiro Shutoh; Tung Le Dinh; Takehito Okamoto; Toshio Ikeda; Michiyuki Suzuki; Shigenori Kawahara; Dai Yanagihara; Yamato Sato; Kazuyuki Yamada; Toshiro Sakamoto; Yutaka Kirino; Nicholas A Hartell; Kazuhiko Yamaguchi; Shigeyoshi Itohara; Angus C Nairn; Paul Greengard; Soichi Nagao; Masao Ito
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-13       Impact factor: 11.205

5.  Gating of long-term depression by Ca2+/calmodulin-dependent protein kinase II through enhanced cGMP signalling in cerebellar Purkinje cells.

Authors:  Shin-ya Kawaguchi; Tomoo Hirano
Journal:  J Physiol       Date:  2013-01-07       Impact factor: 5.182

6.  Role of G-Substrate in the NO/cGMP/PKG Signal Transduction Pathway for Photic Entrainment of the Hamster Circadian Clock.

Authors:  Santiago Andrés Plano; María Soledad Alessandro; Laura Lucía Trebucq; Shogo Endo; Diego Andrés Golombek; Juan José Chiesa
Journal:  ASN Neuro       Date:  2021 Jan-Dec       Impact factor: 4.146

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.